- Home
- GLSI vs FNKO Comparison
GLSI vs FNKO Comparison
Compare GLSI & FNKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLSI
- FNKO
- Stock Information
- Founded
- GLSI 2006
- FNKO 2017
- Country
- GLSI United States
- FNKO United States
- Employees
- GLSI N/A
- FNKO N/A
- Industry
- GLSI Biotechnology: Pharmaceutical Preparations
- FNKO Recreational Games/Products/Toys
- Sector
- GLSI Health Care
- FNKO Consumer Discretionary
- Exchange
- GLSI Nasdaq
- FNKO Nasdaq
- Market Cap
- GLSI 145.2M
- FNKO 170.7M
- IPO Year
- GLSI 2020
- FNKO 2017
- Fundamental
- Price
- GLSI $9.31
- FNKO $2.98
- Analyst Decision
- GLSI Strong Buy
- FNKO Buy
- Analyst Count
- GLSI 1
- FNKO 4
- Target Price
- GLSI $39.00
- FNKO $7.13
- AVG Volume (30 Days)
- GLSI 76.0K
- FNKO 1.0M
- Earning Date
- GLSI 11-13-2025
- FNKO 11-06-2025
- Dividend Yield
- GLSI N/A
- FNKO N/A
- EPS Growth
- GLSI N/A
- FNKO N/A
- EPS
- GLSI N/A
- FNKO N/A
- Revenue
- GLSI N/A
- FNKO $970,702,000.00
- Revenue This Year
- GLSI N/A
- FNKO N/A
- Revenue Next Year
- GLSI N/A
- FNKO $10.57
- P/E Ratio
- GLSI N/A
- FNKO N/A
- Revenue Growth
- GLSI N/A
- FNKO N/A
- 52 Week Low
- GLSI $8.06
- FNKO $2.22
- 52 Week High
- GLSI $15.47
- FNKO $14.65
- Technical
- Relative Strength Index (RSI)
- GLSI 33.14
- FNKO 40.95
- Support Level
- GLSI $10.00
- FNKO $2.94
- Resistance Level
- GLSI $10.84
- FNKO $3.27
- Average True Range (ATR)
- GLSI 0.54
- FNKO 0.18
- MACD
- GLSI -0.13
- FNKO -0.04
- Stochastic Oscillator
- GLSI 1.14
- FNKO 14.71
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
About FNKO Funko Inc.
Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.